FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jeffrey Mahon

Research Profile

Disorders

Chemicals & Drugs

Procedures

Geographic Areas

Concepts & Ideas

Anatomy

Islets of Langerhans

Co-author Network

Publications

TOP 3
Jay M Sosenko; Craig A Beam; David C Boulware; Catherine Cowie; David Cuthbertson; Carla J Greenbaum; Jeffrey P Krischer; Jeffrey L Mahon; Jerry P Palmer; Lisa Rafkin-Mervis; Jay S Skyler
The application of the diabetes prevention trial-type 1 risk score for identifying a preclinical state of type 1 diabetes.
Jeffrey L Mahon; Santica M Marcovina; Jerry P Palmer; Jay S Skyler; William E Winter; Craig A Beam; David C Boulware; Jeffrey P Krischer
Comparison of two insulin assays for first-phase insulin release in type 1 diabetes prediction and prevention studies.
Jay M Sosenko; Craig A Beam; David C Boulware; Catherine Cowie; David Cuthbertson; Carla J Greenbaum; Jeffrey P Krischer; Jeffrey L Mahon; Jerry P Palmer; Lisa Rafkin-Mervis; Jay S Skyler
Validation of the Diabetes Prevention Trial-Type 1 Risk Score in the TrialNet Natural History Study.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jeffrey Mahon (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Jay M Sosenko; Craig A Beam; David C Boulware; Catherine Cowie; David Cuthbertson; Carla J Greenbaum; Jeffrey P Krischer; Jeffrey L Mahon; Jerry P Palmer; Lisa Rafkin-Mervis; Jay S Skyler
The application of the diabetes prevention trial-type 1 risk score for identifying a preclinical state of type 1 diabetes.
Diabetes care 2012;35(7):1552-5.
2011: Jeffrey L Mahon; Santica M Marcovina; Jerry P Palmer; Jay S Skyler; William E Winter; Craig A Beam; David C Boulware; Jeffrey P Krischer
Comparison of two insulin assays for first-phase insulin release in type 1 diabetes prediction and prevention studies.
Clinica chimica acta; international journal of clinical chemistry 2011;412(23-24):2128-31.
2011: Jay M Sosenko; Craig A Beam; David C Boulware; Catherine Cowie; David Cuthbertson; Carla J Greenbaum; Jeffrey P Krischer; Jeffrey L Mahon; Jerry P Palmer; Lisa Rafkin-Mervis; Jay S Skyler
Validation of the Diabetes Prevention Trial-Type 1 Risk Score in the TrialNet Natural History Study.
Diabetes care 2011;34(8):1785-7.
2011: Jay M Sosenko; Jeffrey L Mahon; Lisa Rafkin-Mervis; John M Lachin; Heidi Krause-Steinrauf; Jeffrey P Krischer; David Cuthbertson; Jerry P Palmer; Clinton Thompson; Carla J Greenbaum; Jay S Skyler
A comparison of the baseline metabolic profiles between Diabetes Prevention Trial-Type 1 and TrialNet Natural History Study participants.
Pediatric diabetes 2011;12(2):85-90.
2011: Sigrid A E Nelson; George K Dresser; Margaret K Vandervoort; Cindy J Wong; Brian G Feagan; Jeffrey L Mahon; Ross D Feldman
Barriers to blood pressure control: a STITCH substudy.
Journal of clinical hypertension (Greenwich, Conn.) 2011;13(2):73-80.
2010: Jay M Sosenko; Jay S Skyler; Jeffrey P Krischer; Carla J Greenbaum; Jeffrey L Mahon; Lisa Rafkin-Mervis; David Cuthbertson; Catherine Cowie; Kevan C Herold; George Eisenbarth; Jerry P Palmer
Glucose excursions between states of glycemia with progression to type 1 diabetes in the diabetes prevention trial-type 1 (DPT-1).
Diabetes 2010;59(10):2386-9.
2009: Jay M Sosenko; Jerry P Palmer; Lisa Rafkin-Mervis; Jeffrey P Krischer; David Cuthbertson; Jeffrey L Mahon; Carla J Greenbaum; Catherine Cowie; Jay S Skyler
Incident dysglycemia and progression to type 1 diabetes among participants in the Diabetes Prevention Trial-Type 1.
Diabetes care 2009;32(9):1603-7.
2009: Jeffrey L Mahon; Jay M Sosenko; Lisa Rafkin-Mervis; Heidi Krause-Steinrauf; John M Lachin; Clinton Thompson; Polly J Bingley; Ezio Bonifacio; Jerry P Palmer; George S Eisenbarth; Joseph Wolfsdorf; Jay S Skyler
The TrialNet Natural History Study of the Development of Type 1 Diabetes: objectives, design, and initial results.
Pediatric diabetes 2009;10(2):97-104.
2009: Rita S Suri; Jeffrey L Mahon; William F Clark; Louise Moist; Marina Salvadori; Amit X Garg
Relationship between Escherichia coli O157:H7 and diabetes mellitus.
Kidney international. Supplement 2009;(112):S44-6.
2008: Raj J Padwal; Brenda R Hemmelgarn; Nadia A Khan; Steven Grover; Finlay A McAlister; Donald W McKay; Thomas Wilson; Brian Penner; Ellen Burgess; Peter Bolli; Michael D Hill; Jeffrey L Mahon; Martin G Myers; Carl Abbott; Ernesto L Schiffrin; George Honos; Karen Mann; Guy Tremblay; Alain Milot; Lyne Cloutier; Arun Chockalingam; Simon W Rabkin; Martin Dawes Dawes; Rhian M Touyz; Chaim Bell; Kevin D Burns; Marcel Ruzicka; Norman R C Campbell; Marcel Lebel; Sheldon W Tobe
The 2008 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 1 - blood pressure measurement, diagnosis and assessment of risk.
The Canadian journal of cardiology 2008;24(6):455-63.
2007: Raj Padwal; Brenda R Hemmelgarn; Finlay A McAlister; Donald W McKay; Steven Grover; Thomas Wilson; Brian Penner; Ellen Burgess; Peter Bolli; Michael Hill; Jeffrey L Mahon; Martin G Myers; Carl Abbott; Ernest L Schiffrin; George Honos; Karen Mann; Guy Tremblay; Alain Milot; Lyne Cloutier; Arun Chockalingam; Nadia A Khan; Simon W Rabkin; Martin Dawes; Rhian M Touyz; Sheldon W Tobe
The 2007 Canadian Hypertension Education Program recommendations for the management of hypertension: part 1- blood pressure measurement, diagnosis and assessment of risk.
The Canadian journal of cardiology 2007;23(7):529-38.
2007: George Rodrigues; Glenn Bauman; Michael Lock; David D'Souza; Jeffrey L Mahon
Psychometric properties of a prostate cancer radiation late toxicity questionnaire.
Health and quality of life outcomes 2007;5():29.
2006: Kelly L Summers; Annette M Marleau; Jeffrey L Mahon; Ruth McManus; Irene Hramiak; Bhagirath Singh
Reduced IFN-alpha secretion by blood dendritic cells in human diabetes.
Clinical immunology (Orlando, Fla.) 2006;121(1):81-9.
2006: Zia Ali KHAN; Hana Farhangkhoee; Jeffrey L Mahon; Lynda Bere; John R Gonder; Bosco M C Chan; Shashi Uniyal; Subrata Chakrabarti
Endothelins: regulators of extracellular matrix protein production in diabetes.
Experimental biology and medicine (Maywood, N.J.) 2006;231(6):1022-9.
2005: Rita S Suri; William F Clark; Nicholas J Barrowman; Jeffrey L Mahon; Heather R Thiessen-Philbrook; M Patricia Rosas-Arellano; Kelly B Zarnke; Jocelyn S Garland; Amit X Garg
Diabetes during diarrhea-associated hemolytic uremic syndrome: a systematic review and meta-analysis.
Diabetes care 2005;28(10):2556-62.
2005: Charlotte G McDonald; Sumit R Majumdar; Jeffrey L Mahon; Jeffrey Johnson
The effectiveness of beta-blockers after myocardial infarction in patients with type 2 diabetes.
Diabetes care 2005;28(9):2113-7.
2004: Chris Blanchard; David Feeny; Jeffrey L Mahon; Robert Bourne; Cecil H Rorabeck; Larry Stitt; Susan Webster-Bogaert
Is the Health Utilities Index valid in total hip arthroplasty patients?
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2004;13(2):339-48.
2004: David Feeny; C M Blanchard; Jeffrey L Mahon; Robert Bourne; Cecil H Rorabeck; Larry Stitt; Susan Webster-Bogaert
The stability of utility scores: test-retest reliability and the interpretation of utility scores in elective total hip arthroplasty.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2004;13(1):15-22.
2004: Nadia A Khan; Finlay A McAlister; Norman R C Campbell; Ross D Feldman; Simon Rabkin; Jeffrey L Mahon; Richard Z Lewanczuk; Kelly B Zarnke; Brenda R Hemmelgarn; Marcel Lebel; Mitchell Levine; Carol Herbert
The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.
The Canadian journal of cardiology 2004;20(1):41-54.
2003: James McKinney; Henian Cao; Margaret T Behme; Jeffrey L Mahon; Robert A Hegele
Maturity-onset diabetes of the young (MODY) mutation in type 2 diabetes and latent autoimmune diabetes of the adult.
Diabetes care 2003;26(12):3358-9.
2003: Margaret T Behme; J Dupre; S B Harris; Irene Hramiak; Jeffrey L Mahon
Insulin resistance in latent autoimmune diabetes of adulthood.
Annals of the New York Academy of Sciences 2003;1005():374-7.
2003: Kelly L Summers; Margaret T Behme; Jeffrey L Mahon; Bhagirath Singh
Characterization of dendritic cells in humans with type 1 diabetes.
Annals of the New York Academy of Sciences 2003;1005():226-9.
2003: Ramesh L Sahjpaul; Jeffrey L Mahon; Samuel Wiebe
Dexamethasone for morbidity after subdural electrode insertion--a randomized controlled trial.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 2003;30(4):340-8.
2003: Chris Blanchard; David Feeny; Jeffrey L Mahon; Robert Bourne; Cecil H Rorabeck; Larry Stitt; Susan Webster-Bogaert
Is the Health Utilities Index responsive in total hip arthroplasty patients?
Journal of clinical epidemiology 2003;56(11):1046-54.
2003: Hui-Yu Qin; Jeffrey L Mahon; Mark A Atkinson; Pratibha Chaturvedi; Edwin Lee-Chan; Bhagirath Singh
Type 1 diabetes alters anti-hsp90 autoantibody isotype.
Journal of autoimmunity 2003;20(3):237-45.
2003: David Feeny; Christopher Blanchard; Jeffrey L Mahon; Robert Bourne; Cecil H Rorabeck; Larry Stitt; Susan Webster-Bogaert
Comparing community-preference-based and direct standard gamble utility scores: evidence from elective total hip arthroplasty.
International journal of technology assessment in health care 2003;19(2):362-72.
2002: David Massel; David G McCormack; James Lewis; Jeffrey L Mahon
Research of the holiday kind. Stableford: equitable golf-scoring system or quality-of-life measure?
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2002;167(12):1337-40.
2002: Jeffrey L Mahon; Robert B Bourne; Cecil H Rorabeck; David Feeny; Larry Stitt; Susan Webster-Bogaert
Health-related quality of life and mobility of patients awaiting elective total hip arthroplasty: a prospective study.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2002;167(10):1115-21.
2002: Finlay A McAlister; Kelly B Zarnke; Norman R C Campbell; Ross D Feldman; Mitchell Levine; Jeffrey L Mahon; Steven A Grover; Richard Z Lewanczuk; Frans Leenen; Sheldon Tobe; Marcel Lebel; James Stone; Ernesto L Schiffrin; Simon W Rabkin; Richard I Ogilvie; Pierre Larochelle; Charlotte Jones; George Honos; George Fodor; Ellen Burgess; Pavel Hamet; Robert Herman; Jane Irvine; Bruce Culleton; James M Wright
The 2001 Canadian recommendations for the management of hypertension: Part two--Therapy.
The Canadian journal of cardiology 2002;18(6):625-41.
2002: Margaret T Behme; Jeffrey L Mahon; J Dupre
Autoantibodies and HLA susceptibility markers in Canadian first-degree relatives of patients with type 1 diabetes.
Annals of the New York Academy of Sciences 2002;958():228-31.
2002: J W D McDonald; Jeffrey L Mahon; Kelly B Zarnke; Brian G Feagan; Lorinda Simms; Wayne Tucker
A randomized survey of the preference of gastroenterologists for a Cochrane review versus a traditional narrative review.
Canadian journal of gastroenterology = Journal canadien de gastroenterologie 2002;16(1):17-21.
2001: Jennifer M Jakobi; DW Killinger; B M Wolfe; Jeffrey L Mahon; Charles L Rice
Quadriceps muscle function and fatigue in women with Addison's disease.
Muscle & nerve 2001;24(8):1040-9.
2000: Jeffrey L Mahon
Direct and indirect randomized trials of screening: the A's and D's of evidence-based clinical practice guidelines.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2000;162(7):1002-4.
1999: Carl van Walraven; Jeffrey L Mahon; David Moher; C Bohm; Andreas Laupacis
Surveying physicians to determine the minimal important difference: implications for sample-size calculation.
Journal of clinical epidemiology 1999;52(8):717-23.
1999: Jeffrey L Mahon; A Laupacis; R V Hodder; D A McKim; N A Paterson; T E Wood; A Donner
Theophylline for irreversible chronic airflow limitation: a randomized study comparing n of 1 trials to standard practice.
Chest 1999;115(1):38-48.
1998: M Edmonds; M Bauer; S Osborn; H Lutfiyya; Jeffrey L Mahon; Gordon S Doig; P Grundy; C Gittens; G Molenkamp; Deborah Fenlon
Using the Vista 350 telephone to communicate the results of home monitoring of diabetes mellitus to a central database and to provide feedback.
International journal of medical informatics 1998;51(2-3):117-25.
1997: Jeffrey L Mahon; J Dupre
The limitations of clinical trials for prevention of IDDM.
Diabetes care 1997;20(6):1027-33.
1997: Kelly B Zarnke; B G Feagan; Jeffrey L Mahon; Ross D Feldman
A randomized study comparing a patient-directed hypertension management strategy with usual office-based care.
American journal of hypertension 1997;10(1):58-67.
1996: Jeffrey L Mahon; A Laupacis; A Donner; T Wood
Randomised study of n of 1 trials versus standard practice.
BMJ (Clinical research ed.) 1996;312(7038):1069-74.
1995: Jeffrey L Mahon; Brian G Feagan; A Laupacis
Ethics of n-of-1 trials.
Lancet 1995;345(8955):989.
1993: Jeffrey L Mahon; J Dupre; C R Stiller
Lessons learned from use of cyclosporine for insulin-dependent diabetes mellitus. The case for immunotherapy for insulin-dependent diabetics having residual insulin secretion.
Annals of the New York Academy of Sciences 1993;696():351-63.
1993: T L Paul; Irene Hramiak; Jeffrey L Mahon; D Freeman; Paul Atkison; D T Finegood; J Dupre
Nicotinamide and insulin sensitivity.
Diabetologia 1993;36(4):369.
1992: P Chase; J Dupre; Jeffrey L Mahon; R Ehrlich; E Gale; H Kolb; E Lampeter; J Nerup
Nicotinamide and prevention of diabetes.
Lancet 1992;339(8800):1051-2.
1991: Jeffrey L Mahon; K Steel; Brian G Feagan; A Laupacis; L L Pederson
Use of acetylsalicylic acid by physicians and in the community.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 1991;145(9):1107-16.
1991: J Dupre; M R Jenner; Jeffrey L Mahon; C Purdon; N W Rodger; C R Stiller
Endocrine-metabolic function in remission-phase IDDM during administration of cyclosporine.
Diabetes 1991;40(5):598-604.
1990: Paul Atkison; Jeffrey L Mahon; J Dupre; C R Stiller; M R Jenner; T L Paul; C I Momah
Interaction of bromocriptine and cyclosporine in insulin dependent diabetes mellitus: results from the Canadian open study.
Journal of autoimmunity 1990;3(6):793-9.
1990: Jeffrey L Mahon; John Dupré; C R Stiller; A P Donner
Immunosuppression in IDDM. Rationale, risks, benefits, and strategies.
Diabetes care 1990;13(7):806-8.
1990: J Dupre; Irene Hramiak; Jeffrey L Mahon; C R Stiller
Induction and pathophysiology of remission of insulin-dependent diabetes mellitus during administration of ciclosporin. London Diabetes Study Group.
Hormone research 1990;33(2-4):152-8.
1988: John Dupré; C R Stiller; M Gent; A Donner; B von Graffenried; D Heinrichs; M Jenner; Paul Keown; Jeffrey L Mahon; R Martell
Clinical trials of cyclosporin in IDDM.
Diabetes care 1988;11 Suppl 1():37-44.
1988: Jeffrey L Mahon; H C Gunn; K Stobie; C Gibson; Bertha Garcia; John Dupré; C R Stiller
The effect of bromocriptine and cyclosporine on spontaneous diabetes in BB rats.
Transplantation proceedings 1988;20(3 Suppl 4):197-200.